Webinar Series
SITC is pleased to offer free webinars featuring Expert Panel members from SITC's Acute Leukemia Immunotherapy Guideline. These educational offerings are designed for healthcare providers who treat cancer patients including oncologists, physicians, disease specialists, registered nurses, nurse practitioners, pharmacists and physician assistants. The live webinars include a dedicated question-and-answer session providing the opportunity for attendees to converse with the faculty and ask questions about the guideline recommendations.
- SITC Clinical Practice Guideline Webinar – Immunotherapy for the Treatment of Acute Leukemia
SITC hosted this session on January 11, 2021 - VIEW ENDURING MATERIALS
In this introductory webinar, Expert Panel members provide attendees with an overview of the published guideline and highlight selected recommendations that are applicable to some of the most common scenarios clinicians may encounter while treating their patients with immunotherapy. After attending this webinar, learners will be better able to implement immunotherapy treatments effectively and in accordance with the recommendations in the SITC CPG.
- Practical Management Pearls for Immunotherapy for the Treatment of Acute Leukemia – SITC CPG Webinar
SITC hosted this session on October 14, 2021 - VIEW ENDURING MATERIALS
This advanced webinar is designed so that attendees will know how to appraise and classify organ-specific considerations for immunotherapy agents and toxicities, identify and manage clinically significant uncommon toxicities, and determine optimal sequencing of immunotherapies in relapsed and/or refractory disease.
- Case Studies in Immunotherapy for the Treatment of Acute Leukemia – SITC CPG Webinar
SITC hosted this session on November 15, 2021 - VIEW ENDURING MATERIALS
Faculty engage attendees through a combination of case presentations with a “virtual tumor board” discussion and Q&A with diverse sub-specialty experts based on the needs of each particular case. This high-level webinar is designed so attendees will be able to execute the use of immunotherapy with increased confidence, plan management strategies for difficult cases, and identify and discuss areas of controversy in the immunotherapy field.